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ABSTRACT OF THESIS

BREAST CANCER TRENDS AMONG KENTUCKY WOMEN, 2004-2007
The purpose of this study is to investigate the discrepancies of female breast cancer
mortality between the Appalachian and Non-Appalachian regions of Kentucky using
data from the Kentucky Cancer Registry. This study identified subtype, reproductive,
and regional differences in women with breast cancer in Kentucky. Among women
with breast cancer living in Kentucky from 2004 to 2007, one and three live births
significantly increased a woman’s risk of breast cancer mortality by 91% and 58%
respectively, compared to a woman with zero live births. Progesterone receptornegative tumor status significantly increased a woman’s risk of breast cancer
mortality by 64% compared to women with progesterone receptor-positive breast
cancer. Residence in the Appalachian region significantly increased a woman’s risk
of breast cancer mortality by 3.14-fold. After adjusting for regional interactions,
progesterone receptor-negative tumor status in the Appalachian region increased a
woman’s risk of breast cancer mortality by 3.13-fold. These findings suggest parity
and estrogen receptor tumor status do not contribute to the breast cancer differences
between the Appalachian and Non-Appalachian region of Kentucky. The association
between progesterone receptor status and Appalachian residency suggest factors
associated with the Appalachian region provide the poorest prognosis for a woman
with breast cancer in Kentucky.
KEYWORDS: Breast cancer, Mortality, Appalachia, Parity, Progesterone
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CHAPTER ONE
Introduction

Background
Breast cancer is the most commonly occurring cancer among women in Kentucky
(Centers for Disease Control and Prevention [CDC], 2010). Research has associated
unfavorable socioeconomic and reproductive factors with an increased risk of female
breast cancer and incidence of specific tumor markers (L. Vona-Davis et al., 2008). NonAppalachian regions have higher incidence rates, whereas Appalachian women
experience higher breast cancer mortality rates (Appalachian Regional Commission
[ARC], 2004). These Appalachian regions of Kentucky are known to have decreased
access to health care, lower personal incomes, and lower rates of breast cancer screening
(Hall, Uhler, Coughlin, & Miller, 2002; McGarvey, Killos, & Cohn, 2011; Wingo et al.,
2008). Other factors unique to the Appalachian region may be significant predictors of
breast cancer incidence and mortality (Katz et al., 2010; McGarvey, et al., 2011).
Therefore, studying how these risk factors predict the vital status of Kentucky women
with breast cancer can aid health professionals in developing educational and
preventative techniques to decrease incidence and mortality in both Appalachian and
Non-Appalachian regions of Kentucky.

Statement of the Purpose
The purpose of this study is to investigate the breast cancer mortality rate
differences among women living in the Appalachian and Non-Appalachian regions of
Kentucky. By investigating the subtype, lifestyle, and reproductive differences between
1

the two regions of Kentucky, investigators and health care professionals can focus their
education efforts, screening procedures, and prevention efforts to the needs of each
region

Research Questions
1. Does the number of live births have an effect on the breast cancer mortality
variation among adult women with breast cancer living in Kentucky?
2. Does the tumor receptor status have an effect on mortality in women with breast
cancer living in Kentucky?
3. What factors contribute to the mortality difference between the Appalachian and
Non-Appalachian region in women with breast cancer living in Kentucky?

Justification
Kentucky is the only state out of the six main Appalachian states, which includes
Ohio, Pennsylvania, Virginia, New York, and West Virginia, whose breast cancer
mortality rate is greater in the Appalachian region than the Non-Appalachian region of
the state (Appalachian Community Cancer Network [ACCN], 2010; ARC, 2009).
Research efforts have established socioeconomic, lifestyle, and reproductive factors to be
associated with mortality and incidence rates in other Appalachian states (Abraham et al.,
2009; Katz, et al., 2010; McGarvey, et al., 2011). However, limited research is available
defining the regional differences of breast cancer mortality between the Appalachian and
Non-Appalachian region of Kentucky (Burris & Andrykowski, 2010; Wingo, et al.,
2008). Thus, research efforts are warranted to explain the relationship of risk factors with
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breast cancer mortality in both the Appalachian and Non-Appalachian regions of
Kentucky in order to help decrease overall breast cancer mortality rates in Kentucky.

Assumptions
This study assumed all data collected by the Kentucky Cancer Registry was
accurate. Secondly, the study also assumes records that were excluded did not skew the
results. Lastly, the study concludes breast cancer mortality in the current cases and future
cases would be related to the diagnosis of breast cancer.

3

CHAPTER TWO
Literature Review
Breast cancer mortality rates in Appalachia Kentucky are significantly higher than
rates in Non-Appalachian regions of the state (Wingo, et al., 2008). Though smoking,
family history, and personal history are established risk factors of female breast cancer
incidence, mortality rate discrepancies of breast cancer between Appalachian and NonAppalachian regions may be linked to reproductive, subtype, or socioeconomic regional
differences (Luo et al., 2011; McDavid, Tucker, Sloggett, & Coleman, 2003; Phipps et
al., 2011; L Vona-Davis & Royce, 2009). The study of these regional differences may
provide insights into understanding and minimizing the risk factors associated with
aggressive breast cancer subtypes.

Pathology of Cancer
The pathology of cancer is an important focus in the research of breast cancer.
Understanding the pathology of breast cancer is essential in the prevention and reduction
of breast cancer, as well as treatment efforts for breast cancer (Lari & Kuerer, 2011;
Ursin et al., 2005).
Current research hypothesizes that mutations in tumor suppressing genes,
imbalances of regulating proteins, and over expressions of tumor receptors are involved
in the proliferation mechanism (Lari et al, 2011).

Breast cancer research links increased

endogenous estrogen and progesterone levels with decreased cell adhesion and increased
trans-epithelial permeability. Decreased levels of trans-epithelial resistance may allow
cancer-causing agents to diffuse easily through the tissue (Bernstein & Lacey, 2011;
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Martin, Das, Mansel, & Jiang, 2007). Cancer cells may fail to promote the expression of
unique receptors on the cell to signal the immune system to execute apoptosis via
cytotoxic T cells (Martin, et al., 2007; L. Vona-Davis & Rose, 2009). The cancer cells
are able to proliferate without mediation from the immune system resulting in metastasis
(Jerry, Dunphy, & Hagen, 2010; Martin, et al., 2007).
However, research is still inconclusive over the exact pathology of breast cancer
pathology. We now know it is not one gene, one risk factor, or one event that causes
breast cancer (Bernstein & Lacey, 2011; Milne et al., 2010; Phipps, et al., 2011). Instead,
we can conclude that there are numerous genes, factors, and events that contribute to the
pathology of breast cancer.

Tumor Receptors
Estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth
factor (HER2) are three tumor markers used to diagnose, determine treatment, and
classify subtypes of breast cancer (Albrektsen, Heuch, & Thoresen, 2010). Researchers
have used these tumor markers to investigate the risk factors of breast cancer subtypes
and the aggressiveness of each subtype (Bernstein & Lacey, 2011). Estrogen receptorpositive and progesterone receptor-positive tumor markers have been characterized to
have more favorable responses to hormonal therapy and better prognoses (Bernstein &
Lacey, 2011; Jerry, et al., 2010). Research proposes reproductive, socioeconomic, and
lifestyle influences to predict specific tumor receptor markers in females with breast
cancer (Bernstein & Lacey, 2011; Burris & Andrykowski, 2010; McGarvey, et al., 2011).
Various subtypes have been associated with different rates of mortality, pathology, and
response to standardized treatment methods Over expressions of tumor receptors have
5

been correlated with tumor cell proliferation in conjunction with mutations in tumor
suppressing genes and imbalances in regulating proteins (Jerry, et al., 2010; Lari &
Kuerer, 2011; Perks & Holly, 2011). A subtype of breast cancer, characterized as
estrogen receptor-negative/progesterone receptor-negative/human epidermal growth
factor receptor 2 negative subtype, also known as “triple-negative,” may have risk factors
that are hormonally or non-hormonally stimulated (Phipps, et al., 2011; Rakha et al.,
2009). In 2011, Phipps et. al. found nulliparity to be associated with an increased risk of
estrogen receptor-positive breast cancer, but it was not associated with the risk of
estrogen receptor-negative or triple-negative breast cancer (2011). Various researchers
have associated this aggressive, unconventional subtype of breast cancer with poor
socioeconomic factors in rural populations (Abraham, et al., 2009; L. Vona-Davis, et al.,
2008). Additional research has also associated obesity, race, young age, and a possible
genetic anomaly with this triple-negative breast cancer subtype (McGarvey, et al., 2011;
Linda Vona-Davis & Rose, 2009). However, research investigating these tumor receptor
markers related to the vital status of adverse socioeconomic regions, specifically the
Appalachian region of Kentucky, is novel and limited.

Reproductive Factors
Research concludes parity, early age of first pregnancy, and premenopausal status
are negatively associated with breast cancer risk in women (Albrektsen, et al., 2010;
Huiyan et al., 2010; Milne, et al., 2010). Research has found high parity to be negatively
associated with breast cancer mortality in adult women (Phipps, et al., 2011). One study
observed a 50% decrease in breast cancer incidence, with a full term pregnancy early in
reproductive life (Jerry, et al., 2010).

Research studies have attributed this decreased
6

risk of breast cancer development to the decreased oscillation of these hormones during
pregnancy versus the nulliparous state (Jerry, et al., 2010; Ursin, et al., 2005). Obesity in
premenopausal women has been correlated with a protective effect against the
development of breast cancer, specifically affecting the levels of endogenous circulation
of ovarian hormones (Conroy et al., 2011; Smigal et al., 2006). Premenopausal breast
cancer has been associated with more aggressive tumor subtypes, larger tumor sizes,
increased lymphatic involvement, and increased recurrence. On the other hand,
postmenopausal status has been associated with less aggressive hormone-stimulated
tumor receptor markers in females with breast cancer (Conroy et al., 2011; Smigal, et al.,
2006; Vona-Davis & Rose, 2009). Yet, postmenopausal obesity has been linked to an
increased risk of breast cancer incidence and decreased vital status. Increased
postmenopausal adipose tissue is thought to stimulate an overproduction of endogenous
hormones that promotes the formation of abnormal breast cells (Conroy, et al., 2011;
Smigal, et al., 2006; Vona-Davis & Rose, 2009). Available epidemiological and hospital
record data for Kentucky limits the ability of researchers to correlate obesity to hormone
stimulated tumor receptor status and mortality rate in both the Appalachian and NonAppalachian region. Therefore, future development of data collection methods including
dietary and anthropometric fields could better promote the development of a better breast
cancer mortality rate prediction model.

Regional Differences
The Appalachian region represents 52 of the 120 counties in the state of Kentucky
(Kentucky Cancer Registry, 2011). This region has been historically categorized as
medically underserved with poor socioeconomic conditions (Hall, et al., 2002). Current
7

literature suggests a need for more research to investigate how socioeconomic factors
influence the mortality rate of women with breast cancer. Researchers hypothesize that
various socioeconomic factors, in addition to tobacco use, reproductive factors, and
genetics have an impact on breast cancer vital status (Huang, Dignan, Han, & Johnson,
2009; Land et al., 2011; L Vona-Davis & Royce, 2009). Poor socioeconomic factors,
including low education rates, low average annual salary, and decreased access to health
care have been correlated to high rates of breast cancer incidence (Burris &
Andrykowski, 2010; McDavid, et al., 2003; Royse & Dignan, 2009).
According to the Appalachian Regional Commission (2009), the average annual
salary of the Appalachian region of Kentucky is $28,979. The socioeconomic status of
this region is of concern since this average salary is more than $5000 less than the
national and state averages and $4,818 less than the remaining United States Appalachian
region. Consequently, this region has the highest poverty rate and lowest high school
graduation rate in all Appalachia (ARC, 2009).
Previous research focusing on cancer knowledge and screening intentions
concluded access to health care to be an important predictor of cancer vital status in the
Appalachian region of Kentucky (McDavid, et al., 2003; Royse & Dignan, 2009). In
2009, Royce and Dignan associated decreased health insurance coverage and screening
education with low levels of screening procedures. The study discovered over 25% of
the study participants did not know there was a test for breast cancer and over half were
unable to identify at least one warning sign of cancer. The population with the lowest
education level was most likely to be among the 56.5% of participants that were unable to
identify any of these warning signs (Royse & Dignan, 2009). The findings provide
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evidence to suggest the Appalachian region of Kentucky is less educated about
preventative measures and the symptoms of breast cancer (Huang, et al., 2009; Royse &
Dignan, 2009).
Research investigating populations in the Appalachian counties of Virginia also
found socioeconomic factors, such as low income, lack of education, and decreased
access to medical care, to contribute to adverse health disparities in Appalachian regions
(McGarvey, et al., 2011). However, this study failed to significantly correlate health
insurance coverage to health care utilization.
Research concludes populations in Appalachia are less likely to seek medical care
due the inconvenient travel associated with seeking specialized care and the lack of
income and insurance coverage to pay medical fees (Burris & Andrykowski, 2010;
Huang, et al., 2009; McDavid, et al., 2003). As a result, individuals are procrastinating
medically necessary screening procedures and delaying preventative care (Royse &
Dignan, 2009). More research involving socioeconomic factors is imperative to generate
a more accurate prediction model for breast cancer vital status.

Tumor Classifications by Stage and Grade
Tumor classifications by stage and grade, are used by medical professionals and
researchers to classify the physical characteristics of cancer cells (Young, Roffers, Reis,
Fritz, & Hurlburt, 2001). Poor socioeconomic factors are linked to less optimal breast
cancer classifications (L Vona-Davis & Royce, 2009). Prolonged diagnosis is associated
with a more aggressive breast cancer progression, more invasive cancer, and negative
vital status (Huang, et al., 2009). The delayed utilization of health care and screening
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procedures may accompany a later stage and higher tumor grade of breast cancer at
diagnosis (Hall, et al., 2002).
The National Cancer Institute’s Surveillance Epidemiology and End Results
classification system is used to classify the progression stage of breast cancer. According
to the 2000 SEER Summary Staging Manual, Stage I is defined as a localized cancer. “A
localized cancer is a malignancy limited to the organ of origin” (Young, et al., 2001).
The cancerous cells are in the fat and breast tissue, which includes the nipple and/or
areola, and have not metastasized to other organs of the body. A cancer is upgraded to
Stage II when it is no longer confined to the breast tissue. Specifically, the cancer has
infiltrated a surrounding tissue or muscle. The cancer is defined as Stage III when the
cancer has spread into the lymphatic system. When the cancer has metastasized in other
organs of the body via tissue and lymphatic system, the breast cancer is categorized as
Stage IV. A less known classification, Stage VII breast cancer is defined as a distant
metastasis with lymphatic involvement. For example, a woman is classified as having
Stage IV if her primary location of cancer is in the breast with a satellite metastasis in the
adrenal gland (Young, et al., 2001). However, it is important to understand there are
limitations to the staging system. Research involving the incorporation of breast cancer
staging may have an increased margin of error depending on the variability of physician
differentiation characteristics and on the ability to accurate classify to cancer associated
with degree of metastatic clarity (Young, et al., 2001).
According to Young et al., (2001), the National Cancer Institute defines tumor
grade as “a system used to classify cancer cells in terms of how abnormal they look under
a microscope and how quickly the tumor is likely to grow and spread.” The scale is 1 – 4,
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with 1 being well differentiated to 4 being undifferentiated or anaplastic. Grade 4
tumors are considered the most aggressive grade (Young, et al., 2001). Research
investigating breast cancer history related to reproductive factors in a Norwegian
population provided evidence to support previous research works associating prolonged
diagnosis, later age at diagnosis, and nulliparity to be associated with a higher
histological grade of breast cancer tumors (Albrektsen, et al., 2010). Poorly
differentiated tumors were most associated with younger age, with the most significance
in nulliparious women. This study emphasized a large gap in breast cancer research.
Current research fails to unify the associations of tumor classifications, reproductive
factors, and socioeconomic influences to breast cancer vital status.
Future researchers should analyze these risk predictors with tumor receptors to
investigate if poorly differentiated tumors in young, nulliparious women are associated
with triple-negative breast cancer. In addition, socioeconomic factors related to tumor
classifications controlling for reproductive and lifestyle factors would construct a more
valid prediction model for breast cancer vital status.
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CHAPTER THREE
Methodology

Research Methods
This research study was approved by the Institutional Review Board (IRB) at the
University of Kentucky, in April 2011. Once the study was approved, applications were
submitted to the Kentucky Cancer Registry to obtain research data fields. Permission to
use the data was granted by the Kentucky Cancer Registry review panel in May 2011.
The Kentucky Cancer Registry informatics staff created a de-identified data file that was
transferred over the Kentucky Cancer Registry secure transfer site. The data was
accessed using an assigned username and password. The data included individual,
record-level data with no personal identifiers.
This study used a cross-sectional observational epidemiologic framework. The
data supplied by the Kentucky Cancer Registry provided demographic, reproductive,
histological, and lifestyle information for analysis.

Research Scope
The study used all primary cases of breast cancer in adult females, age 18 and
over, living in Kentucky between years 2004 and 2007.

Study Population
The study population included all female breast cancer cases in Kentucky from
2004-2007. The original sample included 11,822 breast cancer records in the female
population of 8,543,939 at risk (Kentucky Cancer Registry [KCR], 2011). Women that
12

died due to accidental events not associated with medical diagnosis were excluded from
this study and thus, did not contribute to case analysis. After excluding cases not meeting
parameters of the study project, 11,814 cases were used for the statistical analysis. The
final study population included 8642 Non-Appalachian and 3172 Appalachian women.

Statistical Analysis
This study used SPSS ® Version 20 to assess breast cancer mortality among adult
females with breast cancer living in Kentucky between 2004 and 2007. Descriptive
statistics and chi-square analyses were calculated to compare ethnicity, residence,
tobacco use, number of live births, and estrogen and progesterone receptor tumor status
between the Appalachian and Non-Appalachian region of Kentucky. Separate adjusted
and unadjusted multivariate logistic regression models were constructed for parity,
region, and tumor receptor status. Mortality was considered the dependent variable. The
full model adjusted for age, ethnicity, tumor status, tumor grade, tumor stage, family
history, tobacco use, and menopausal status. An additional multivariate logistic
regression model used backward elimination to analyze the interactions of the fulladjusted model.
Number of live births, the main variable, was divided into 5 categories --- 0, 1, 2,
3 and 4 or more live births (Whiteman et al., 2004). Tobacco use was categorized as “yes
tobacco use” or “no tobacco use,” considering cigarette, cigar, and chewing tobacco
history. Tumor grade was categorized according to the clinical TNM stage grouping from
the cTNM classification using the AJCC Cancer Staging Manual as tumor grade I, II, III,
and IV (KCR, 2011). Tumor stage was coded according to Kentucky Cancer Registry’s
coding protocol using coding guidelines in Appendix C of the SEER Program Coding
13

and Staging Manual (KCR, 2011). Tumor stage was further categorized as “early stage”
and “late stage.” Tumors that were “SEER Stage I” and “SEER Stage II” were
considered “early stage.” Tumors that were advanced past SEER Stage II were
considered “late stage” (Huang, et al., 2009). Race was categorized as white, or nonwhite (McDavid, et al., 2003). Recurrence was categorized as recurred or non-recurring
breast cancer. Estrogen receptor and Progesterone receptor tumor status was considered
positive or negative. An additional variable, age at diagnosis, was created subtracting
date of birth from date of diagnosis (Albrektsen, et al., 2010). Tumor behavior was
considered invasive or in-situ. Family history, number of primaries, and menopausal
status were also included in the model. Postmenopausal status was assumed for
incomplete data fields with age greater than or equal to 65 years old. The entire data set
was received from the Kentucky Cancer Registry stratified by region according to
residence in the Appalachian and Non-Appalachian region of Kentucky. Appalachian
counties were designated by the Kentucky Cancer Registry as the 52 following counties:
Adair, Bath, Bell, Boyd, Breathitt, Carter, Casey, Clark, Clay, Clinton, Cumberland,
Elliott, Estill, Fleming, Floyd, Garrard, Green, Greenup, Harlan, Jackson, Johnson, Knott,
Knox, Laurel, Lawrence, Lee, Leslie, Letcher, Lewis, Lincoln, Madison, Magoffin,
Martin, McCreary, Menifee, Metcalfe, Monroe, Montgomery, Morgan, Nicholas,
Owsley, Perry, Pike, Powell, Pulaski, Robertson, Rockcastle, Rowan, Russell, Wayne,
Whitley, Wolfe.
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This study used a cross-sectional observational epidemiologic framework. The
data supplied by the Kentucky Cancer Registry provided demographic, reproductive,
histological, and lifestyle information for analysis.
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CHAPTER FOUR
Results

Demographics
Demographic characteristics for the breast cancer registry patients in Kentucky
are listed in Table 1. From 2004 – 2007, 93.3% of the population was white with 26.8%
of women with breast cancer in Kentucky were living in the Appalachian region and
73.20% living in the Non-Appalachian region of Kentucky. The mean age of diagnosis
was 61.03 years of age. Progesterone receptor-positive and estrogen receptor tumor
status was predominantly positive with 64.2% and 75.9%, respectively. More than 60%
of the women were non-smokers. The number of live births for women with breast
cancer in Kentucky was 12.8%, 19.9%, 32.6%, 18.8%, and 15.8% for no live births, one,
two, three, and four or more live births, respectively.
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Table 1. Demographic Characteristics of Breast Cancer Registry Patients in
Kentucky, 2004-2007.
Mean (SD) or Percentage
Ethnicity
White

93.3%

Non-White
Age

6.8%
61.03 (13.84)

Residence
Appalachia resident

26.8%

Non-Appalachia resident

73.2%

Progesterone Receptor
PR+

64.2%

PR-

35.8%

Estrogen Receptor
ER+

75.9%

ER-

24.4%

Tobacco Use
No

60.7%

Yes

39.3%

Number of Live Births
0

12.8%

1

19.9%

2

32.6%

3

18.8%

4 or greater

15.8%

17

Reproductive Differences
The data in Table 2 show that one live birth and three live births significantly
increases an adult woman’s risk of breast cancer mortality by 91% and 58%, respectively,
after adjusting for age, ethnicity, tumor status, family history, tobacco use, tumor grade,
menopausal status, tumor behavior, tumor stage, and region in Kentucky. Before
adjusting for these factors, one, two, and three live births were not significant in
predicting mortality among adult women living in Kentucky during 2004 and 2007.
However, four or more live births did show a significant 57% increase in breast cancer
mortality. The adjusted and unadjusted models had an overall p-value <.001.

18

19

104
193
223
156
186

0

1

2

3

4+

704

903

1612

927

619

No. of non-cases

1.573**

1.03

0.82

1.24

REF

OR unadjusted

** p <0.01

	
  
	
  

	
  

1.41

1.58*

1.21

1.91**

REF

OR adjusted

	
  

1.21-2.05

0.79-1.35

0.64-1.06

0.96-1.61

95% CI

	
  

	
  

0.89-2.23

1.00-2.50

0.78-1.86

1.20-3.00

95% CI

	
  
	
  
	
  
	
  
	
  
Adjusted for age, ethnicity, ER/PR, family history, tobacco use, recurrence, menopausal status, region, tumor grade,
stage, and behavior.

* p <0.05

	
  
Abbreviations: CI, Confidence Interval; OR, Odds Ratio

0 live births is reference

No. of cases

Parity

Table 2. Number of Live Births and Odds Ratio of Breast Cancer Mortality among Adult Women in Kentucky,
2004-2007.

Tumor Receptor Status
The data in Table 3 show that progesterone receptor-negative tumor status
significantly increases an adult woman’s risk of breast cancer mortality by 64% after
adjusting for age, ethnicity, tumor status, family history, tobacco use, tumor grade, parity,
menopausal status, tumor behavior, tumor stage, and region in Kentucky. Estrogen
receptor status was not a significant predictor in the adjusted model. Both estrogen
receptor and progesterone receptor-negative status was associated with a significant
increase in a woman’s risk for breast cancer mortality between 2004 and 2007,
unadjusted for other covariates. A backwards elimination logistic regression model
showed a significant interaction between Appalachia and progesterone receptor tumor
status. The resulting odds ratio of the interaction model showed a 3.13 fold increase in
breast cancer mortality for a woman with progesterone receptor-negative breast cancer
living in the Appalachian region compared to a women with progesterone receptornegative in the Non-Appalachian Kentucky between 2004 and 2007. The adjusted and
unadjusted models had an overall p-value <.001.

20

21

6606
5585

1060
818

1.72**

1.30**
1.48-2.00

1.11-1.53

95% CI

1.64**

1.07

OR-adjusted

1.18-2.28

0.74-1.54

95% CI

Adjusted for age, ethnicity, tumor status, family history, tobacco use, tumor grade, tumor stage, recurrence,
menopausal status, parity, region

* p <0.05, ** p <0.01

Abbreviations: CI, Confidence Interval; OR, Odds Ratio

Reference is (+) for each level of hormone

Progesterone receptor (-)

Estrogen receptor (-)

No. cases No. non-cases OR unadjusted

Table 3. Receptor Type and Odds Ratio of Breast Cancer Mortality of Adult Women in Kentucky, 2004-2007.

Regional Differences
The data in Table 4 show that women with breast cancer living in the Appalachian
region of Kentucky between 2004 and 2007 have a 1.23 fold unadjusted and 3.14 fold
adjusted increase in breast cancer mortality risk compared to women with breast cancer
in Non-Appalachia. A Pearson’s chi-square confirmed the mortality rate among women
in Kentucky with breast cancer was significantly different with a 19.6% mortality rate in
the Appalachian region, compared to 16.6% mortality rate in the Non-Appalachian region
of Kentucky. The mortality difference is consistent with the literature and government
statistics (Halverson et al., 2004).
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23

1431

7211

No. non-cases
1.23**

OR unadjusted

** p <0.01

1.11-1.37

95% CI
3.14*

OR-adjusted

1.10-8.91

95% CI

Adjusted for age, ethnicity, ER/PR, family history, tobacco use, recurrence, menopausal status, parity, tumor
grade, stage, and behavior.

* p <0.05

Abbreviations: CI, Confidence Interval; OR, Odds Ratio

Reference is Non-Appalachia Residence

Appalachia

No. cases

Table 4. Residence in Kentucky and Odds Ratio of Breast Cancer Mortality among Adult Women in Kentucky,
2004-2007.

CHAPTER FIVE
Discussion
The purpose of this study is to investigate the breast cancer mortality rate
differences among women living in the Appalachian and Non-Appalachian regions of
Kentucky. Specifically, the research questions aimed to determine if the breast cancer
mortality rate was increased in the Appalachian region of Kentucky due to a more
aggressive subtype of breast cancer or other socioeconomic, reproductive, or lifestyle
factors.
The limitations of this study should be considered when interpreting the results.
This cross-sectional study is subject to several limitations. First, this study analyzed
adult women with breast cancer living in Kentucky between 2004 and 2007. Therefore,
the results cannot be extrapolated to women without breast cancer, females under the age
of 18, men with breast cancer, or women living outside of Kentucky between 2004 and
2007. Next, additional factors to define lifestyle, reproductive, and socioeconomic status
were not analyzed in the model. Thus, BMI, education, income, environment, genetic
sequences, age at first pregnancy, age at first menstrual cycle, nutritional status, dietary
consumption, and other undefined factors were not included in this model. Yet, the main
impediment to this research is the degree of missingness of the main variable parity. In
addition, excluded incomplete records were more likely to be collected from the
Appalachian region, which may have also biased the results. However, multiple
imputations of all variables with logistic regression, excluding parity, justified the
selection of the original model.
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The first research question asked if the number of live births had an effect on the
breast cancer mortality variation among adult women with breast cancer living in
Kentucky. The researcher initially expected parity to be negatively associated with
mortality. However, the data contradicted this hypothesis. After further review of
literature, the researcher found a majority of the previous research to investigate parity
with breast cancer incidence instead of mortality. Few studies have examined the
association of parity after a woman has been diagnosed with breast cancer. An article in
2009, highlighted this discrepancy and concluded women with four or more children,
using data from a Swedish Cancer Registry, were found to have a poorer prognosis
compared to women with one live birth (S. Butt et al., 2009). Further review found a
similar study in U.S. women to yield results concluding parity increases a woman’s risk
of breast cancer mortality (Whiteman, et al., 2004). Possible explanations for this result
would be explained by an enhanced initiation of breast cancer proliferation related to
pregnancy (Butt, Borgquist, Anagnostaki, Landberg, & Manjer, 2009; Butt, et al., 2009;
Whiteman, et al., 2004). During a woman’s lifetime, endogenous hormones oscillate
according to menstrual cycle and pregnancy (Butt, et al., 2009; Ursin et al., 2005). These
endogenous hormones may have an effect on the proliferation of breast cancer cells by
providing a susceptible physiological state for abnormal cell proliferation (Butt, et al.,
2009; Ursin, et al., 2005). On the other hand, non-hormonal influences that have not
been suppressed by the protective effect of parity may also affect the rate of mortality
(Phipps, et al., 2011; Whiteman, et al., 2004). In addition, factors such as BMI related to
increased adipose tissue, menopausal status, and oral contraceptive use may contribute to
risk estimates observed. However, the exact effect of parity on the initiation and
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pathology of breast cancer mortality is still unclear and cannot be defined by this research
study. Thus, more invasive research is needed.
The second research question asked if breast cancer tumor receptor status had an
effect on mortality in women with breast cancer living in Kentucky. This study found
progesterone receptor-negative status to be significantly associated with breast cancer
mortality in Kentucky. Furthermore, after adjusting for the other variables and the
interaction term the study found a significant increase in breast cancer mortality for a
woman with progesterone receptor-negative breast cancer versus progesterone receptornegative breast cancer living in the Appalachian region of Kentucky between 2004 and
2007. The researcher did not expect to see the degree of increased risk related to region
as observed by the data. Progesterone receptor-negative status is a very aggressive tumor
subtype characterized to have a poor prognosis (Lari et al, 2011; Phipps et al, 2011).
These results raise the question if this aggressive tumor subtype’s poor prognosis is
exacerbated by poor socioeconomic status, as observed in the Appalachian region of
Kentucky or is there additional unknown cofounders that have not been investigated?
The third research question asked what factors contribute to the mortality
difference between the Appalachian and Non-Appalachian region in women with breast
cancer living in Kentucky. A logistic regression model concluded a significant increase
in breast cancer mortality in the Appalachian region of Kentucky. Progesterone receptor
status and number of primaries were the most significant in predicting mortality in this
population. Literature supports these findings (Smigal, et al., 2006; Ursin, et al., 2005).
However, a backwards elimination regression model selecting for interactions between
region versus parity, menopausal status, age at diagnosis, family history, tumor behavior,
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recurrence, and ethnicity were not significant. This may be due to the large amount of
missingness in the data or the small population size of women with breast cancer in years
2004 to 2007, versus a larger selection of years. In addition, other risk factors such as
BMI, education, income, insurance, and travel distance were not included in this model,
which could have been factors in the increased mortality rates. Therefore, this data
cannot reliably provide enough evidence to define the breast cancer mortality rate
differences between the two regions. Instead, this data can only confirm that there is a
difference in mortality between the two regions and that more research is necessary to
define these interactions.
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CHAPTER SIX
Conclusion
This study concluded reproductive differences and estrogen receptor tumor status
between the Appalachian and Non-Appalachian region of Kentucky do not contribute to
the difference in mortality between the two regions. However, progesterone receptor
tumor status did provide evidence to suggest aggressive tumor receptor subtype
differences may contribute to the regional mortality variation. Progesterone receptornegative subtype, an aggressive form of breast cancer, was the most indicative predictor
of breast cancer mortality in adult women living in the Appalachian region of Kentucky.
This suggest women in the Appalachian region are more likely to die of breast cancer if
they have progesterone receptor-negative breast cancer than if they live the NonAppalachian region of Kentucky. However, progesterone receptor-negative status may
also have addition socioeconomic influences that were not included in the risk
assessment.
The results of this study provide some epidemiological evidence that parity,
receptor subtype, and socioeconomic factors are involved in the risk of breast cancer
mortality. Limited research has investigated breast cancer mortality among Kentucky
women, specifically between the Appalachian and Non-Appalachian regions of
Kentucky. In comparison to previous studies that focused on risk assessment of parity to
incidence of breast cancer, this study analyzed the effect of parity on the risk of breast
cancer mortality. This study provided support for the novel research associating
increased parity to be positively associated with breast cancer mortality. In addition, this
study provided support to infer poor socioeconomic factors, associated with the
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Appalachian region, provide the poorest prognosis for a woman with breast cancer in
Kentucky. Socioeconomic, as well as environmental and lifestyle factors unique to the
Appalachian region such as lower high school graduation rates, increased obesity rates,
decreased access to healthcare, delayed diagnoses, and poor nutritional statuses may pose
a significant risk of breast cancer mortality in these Kentucky women.
These findings have important implications for developing educational,
preventative, and research techniques to decrease mortality in both the Appalachian and
Non-Appalachian regions of Kentucky. Prevention efforts should be aimed at
addressing and improving socioeconomic factors, increasing access to health care, and
continued efforts researching the breast cancer risk factors among Kentucky women.
Early mammograms should be encouraged by establishing funding from organizations to
provide free mammograms in socioeconomically deprived areas of Kentucky. In
addition, Kentucky can take strides to improve cancer registry data quality by
encouraging hospitals to record accurate and complete data records. This would decrease
the amount of missingness in the cancer registry data. Furthermore, a cancer registry
database could be developed to include dietary, lifestyle, and socioeconomic data. This
database would provide a comprehensive tool for researchers to better define risk factors
associated with breast cancer.
Future investigation is needed to better establish risk assessment models
incorporating socioeconomic, reproductive, and lifestyle factors to aid in the prevention
of breast cancer mortality in Kentucky women. Prospective studies should compare
breast cancer data between Area District Development Regions to better categorize
socioeconomic influences. Current research also shows nutritional status may prove to
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be an important predictor in the vital status of breast cancer.

The proposed research

should analyze Kentucky breast cancer medical data against dietary and socioeconomic
data. Future research efforts are warranted to define the relationship between dietary
intake and subtypes by controlling for socioeconomic factors. In conclusion,
socioeconomic influences related to nutritional status, lifestyle factors, and reproductive
factors are an important topic for further study.
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Appendix B: Definition of Terms
Appalachian region of Kentucky – 52 counties in the state of Kentucky which include
Adair, Bath, Bell, Boyd, Breathitt, Carter, Casey, Clark, Clay, Clinton, Cumberland,
Elliott, Estill, Fleming, Floyd, Garrard, Green, Greenup, Harlan, Jackson, Johnson, Knott,
Knox, Laurel, Lawrence, Lee, Leslie, Letcher, Lewis, Lincoln, Madison, Magoffin,
Martin, McCreary, Menifee, Metcalfe, Monroe, Montgomery, Morgan, Nicholas,
Owsley, Perry, Pike, Powell, Pulaski, Robertson, Rockcastle, Rowan, Russell, Wayne,
Whitley, Wolfe (Kentucky Cancer Registry, 2011)
Nulliparity – Zero live births of a woman (Salma Butt, et al., 2009)
Number of live births – Refers to the actual number of offspring born alive. (Kentucky
Cancer Registry, 2011)
Number of primaries - Number of recorded primary cancer sites (Kentucky Cancer
Registry, 2011)
Parity – Number of live children born from a woman (Salma Butt, et al., 2009; Ursin, et
al., 2005)
Tumor-receptor – protein biological marker on the surface of a cancer cell (Bernstein &
Lacey, 2011; Jerry, et al., 2010; Lari & Kuerer, 2011)
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